MG
Myriad Genetics Inc
🇺🇸XNAS.MYGNUnited StatesHealthcare
$3.86USDdown -0.03 (-0.77%)OpenDelayed3:31 PM
Price$3.86-0.03 (-0.77%)
Profile
- Healthcare
- Diagnostics & Research
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US62855J1043
- CUSIP
- 62855J104
Company
- Employees
- 2,700
- Headquarters
- Salt Lake City, United States
- Website
- https://www.myriad.com
- CEO
- Mr. Samraat S. Raha
Market
- Shares outstanding
- 95.6M
- Market cap
- $369.21M
Key dates
- Next earnings
- Nov 2, 2026
Highlights
- Market cap
- $354.86M
- EPS LTM
- -$1.19
- P/E LTM
- -4.74
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $806.6M-3.16%down year on year
- Net income
- -$112.6M+71.51%up year on year
- Gross margin
- 68.83%-2.28%down year on year
- Free cash flow
- -$8.6M+80.54%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.